Latest Nzx News

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

Smartpay Holdings Limited reported a 9% increase in revenue to NZD 104.7 million for FY2025 but recorded a net loss and suspended its dividend, signaling challenges ahead despite top-line growth.

Turners Automotive Group has updated its dividend details for the quarter ending March 2025, declaring a fully franked ordinary dividend alongside a supplementary unfranked payout and a Dividend Reinvestment Plan with a 2% discount.

TruScreen Group Ltd reports a dip in FY25 sales but forecasts a robust rebound in FY26 driven by resumed programs and expansion in key emerging markets. Strategic partnerships and AI-enabled technology underpin its growth ambitions.

EROAD Limited reported solid financial results for FY25, with revenue up 6.8% to NZ$194.4 million and a substantial improvement in free cash flow to NZ$16 million. The company’s strategic focus on enterprise fleet growth and innovation underpins a confident FY26 guidance.

Chorus Limited has lodged a replacement Product Disclosure Statement for its $170 million Capital Notes offer, confirming S&P’s equity content treatment and updating key offer dates and terms.

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.

Serko Limited reported a robust 27% increase in total income to NZD 90.5 million for FY25, driven by strong demand in Booking.com for Business and the strategic acquisition of GetThere. The company also highlighted significant progress in operational efficiency, AI capabilities, and sustainability initiatives.

Ampol Limited is divesting its retail electricity businesses in New Zealand and Australia to sharpen its focus on electric vehicle charging and renewable fuels, aiming for a leaner, more profitable energy future.